Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
EPS Diluted Over TimeExpanding
Percentile Rank100
3Y CAGR+44.0%
5Y CAGR+2.3%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
+44.0%/yr
vs +63.2%/yr prior
5Y CAGR
+2.3%/yr
Recent acceleration
Acceleration
-19.2pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | 4.66 | +41.6% |
| 2024 | 3.29 | +33.2% |
| 2023 | 2.47 | +58.3% |
| 2022 | 1.56 | +69.6% |
| 2021 | 0.92 | -77.9% |
| 2020 | 4.16 | +966.7% |
| 2019 | 0.39 | +77.3% |
| 2018 | 0.22 | +113.6% |
| 2017 | -1.62 | +0.6% |
| 2016 | -1.63 | - |